Crescent Grove Advisors’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-726
Closed -$215K 267
2024
Q4
$215K Sell
726
-297
-29% -$85.3K 0.02% 259
2024
Q3
$277K Sell
1,023
-409
-29% -$102K 0.03% 231
2024
Q2
$332K Buy
1,432
+223
+18% +$51.6K 0.04% 201
2024
Q1
$275K Buy
+1,209
New +$251K 0.03% 252
2023
Q2
Sell
-1,666
Closed -$275K 292
2023
Q1
$275K Buy
+1,666
New +$276K 0.03% 245
2022
Q2
Sell
-1,352
Closed -$253K 263
2022
Q1
$253K Sell
1,352
-934
-41% -$169K 0.02% 250
2021
Q4
$374K Buy
+2,286
New +$390K 0.04% 205
2021
Q1
Sell
-1,667
Closed -$202K 211
2020
Q4
$202K Buy
+1,667
New +$185K 0.03% 176

Other funds holding AXP

Crescent Grove Advisors's AXP Position: Q1 2025 in Review

Crescent Grove Advisors sold out of American Express (AXP) in Q1 2025, closing a stake of 726 shares — an estimated $215K sold.

Crescent Grove Advisors first reported a position in AXP in Q4 2020 and held it in 8 quarters. The position peaked at $374K in Q4 2021. 2,613 funds tracked by Wall St. Rank hold AXP as of Q1 2025.

  • Crescent Grove Advisors reported no remaining American Express position as of Q1 2025 after selling out during the quarter.
  • Crescent Grove Advisors sold 726 American Express shares in Q1 2025, an estimated $215K.
  • Crescent Grove Advisors first reported a position in American Express in Q4 2020 and held it in 8 quarters.
  • Crescent Grove Advisors's American Express position peaked at $374K in Q4 2021.
  • 2,613 funds tracked by Wall St. Rank held American Express as of Q1 2025.

Based on Crescent Grove Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.